March 02, 2023
A New Jersey judge largely refused to toss a lawsuit accusing Amarin Pharma of hoarding the active pharmaceutical ingredients needed to produce generic versions of its cardiovascular drug Vascepa, finding that it was possible Amarin acted in bad faith.
April 28, 2021
Dr. Reddy's Laboratories Inc. has said that Amarin Pharma is trying to hinder generic competition of its heart drug Vascepa by cutting deals that keep generic makers from getting their hands on a key ingredient.